STATE STREET CORP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$70,383
+28.6%
334,360
-2.3%
0.00%
Q1 2023$54,730
-85.6%
342,060
-50.0%
0.00%
Q4 2022$379,686
-6.7%
684,120
+100.0%
0.00%
Q3 2022$407,000
+102.5%
342,060
+7.5%
0.00%
Q2 2022$201,000
-90.6%
318,160
-83.1%
0.00%
Q1 2022$2,149,000
-46.9%
1,884,979
+4.8%
0.00%
Q4 2021$4,048,000
-30.7%
1,798,973
+5.4%
0.00%
Q3 2021$5,839,000
+40.4%
1,707,221
+22.8%
0.00%
Q2 2021$4,158,000
+2135.5%
1,390,699
+2314.9%
0.00%
Q1 2021$186,000
+59.0%
57,589
+4.2%
0.00%
Q4 2020$117,000
+80.0%
55,2890.0%0.00%
Q3 2020$65,000
+30.0%
55,2890.0%0.00%
Q2 2020$50,000
+8.7%
55,2890.0%0.00%
Q1 2020$46,000
-13.2%
55,2890.0%0.00%
Q4 2019$53,000
-7.0%
55,2890.0%0.00%
Q3 2019$57,000
-43.0%
55,2890.0%0.00%
Q2 2019$100,000
-3.8%
55,2890.0%0.00%
Q1 2019$104,000
+60.0%
55,2890.0%0.00%
Q4 2018$65,000
-56.7%
55,2890.0%0.00%
Q3 2018$150,000
+31.6%
55,289
-7.2%
0.00%
Q2 2018$114,000
-8.8%
59,6050.0%0.00%
Q1 2018$125,000
+3.3%
59,6050.0%0.00%
Q4 2017$121,000
+36.0%
59,605
-11.6%
0.00%
Q3 2017$89,000
-84.5%
67,405
-81.6%
0.00%
Q2 2017$574,000
-84.1%
367,176
-67.1%
0.00%
Q1 2017$3,605,000
+170.0%
1,116,117
+12.8%
0.00%
Q4 2016$1,335,000
-17.1%
989,060
-4.1%
0.00%
Q3 2016$1,610,000
+17.8%
1,031,377
+0.5%
0.00%
Q2 2016$1,367,000
-70.1%
1,026,314
+18.3%
0.00%
Q1 2016$4,569,000
-72.2%
867,627
-58.5%
0.00%
-100.0%
Q4 2015$16,407,000
-48.0%
2,090,153
-44.0%
0.00%
-50.0%
Q3 2015$31,531,000
-11.5%
3,731,632
+14.6%
0.00%0.0%
Q2 2015$35,647,000
+8.5%
3,255,703
+38.6%
0.00%
+33.3%
Q1 2015$32,846,000
+12.5%
2,349,630
+35.9%
0.00%0.0%
Q4 2014$29,205,000
+25.9%
1,729,006
+0.0%
0.00%
+50.0%
Q3 2014$23,200,000
-7.5%
1,728,984
-12.1%
0.00%
-33.3%
Q2 2014$25,070,000
+0.8%
1,967,894
-5.9%
0.00%0.0%
Q1 2014$24,873,000
-56.9%
2,091,949
-25.6%
0.00%
-25.0%
Q4 2013$57,696,000
+93.0%
2,812,306
+64.1%
0.00%0.0%
Q3 2013$29,895,000
+4.5%
1,713,344
-2.7%
0.00%0.0%
Q2 2013$28,612,0001,760,4870.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders